Genixus Introduces New Propofol RTA Syringe

Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, will offer Propofol as the first product within its KinetiX platform of RTA syringe products at the Annual National Pharmacy Purchasing Association Conference (Booth...

Cohen Children’s Medical Center Unveils $110M Pediatric Surgical Operating Complex

Cohen Children’s Medical Center has announced the opening of the Pediatric Surgical Operating Complex, a $110 million, 24,000-square-foot, state-of-the-art home for pediatric surgery that greatly enhances the capabilities of New York State’s No. 1 provider of...

AAAHC Calls for 2022-23 Bernard A. Kershner Innovations in Quality Improvement Award Submissions

Today, the Accreditation Association for Ambulatory Health Care (AAAHC) opens submissions for the 2022-23 Bernard A. Kershner Innovations in Quality Improvement (QI) Awards. Named in honor of the late Bernard A. Kershner, a leader in ambulatory health care and...

Movano Ring Company Eyes FDA Submission

Movano Inc., a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the successful completion of a study with the University of California San Francisco (UCSF) to assess the accuracy of the Movano Ring’s...

Hensler Bone Press Receives CE Certification

The Hensler Bone Press

Hensler Surgical Technologies has announced its newly obtained CE mark for the Hensler Bone Press (HBP).

“Harvesting drilled graft material is an arduous but necessary undertaking to improve fusion outcomes in a wide array of surgical procedures. We are proud to offer a device that procures this graft material quickly, allowing for the procurement and processing of this critical and valuable autologous resource into a moldable and malleable graft for use in fusion surgeries. I invented it simply out of the need in our own surgical cases, and it grew from there,” said Hensler Surgical CEO and inventor Sean Hensler. “We are excited to expand the range of use for the HBP, as it is tailored for bone fusion cases, internationally. The entire Hensler team has worked very hard on this milestone.”

It is well established the patient’s own bone is the “gold standard” for bone grafting fusion cases. Hensler Surgical brought the Hensler Bone Press to market in 2012. The HBP is being used in surgery domestically and in select foreign countries, not observing the CE mark … until now. The HBP has indications for not just spinal surgery, but additionally for orthopedic surgical cases to harvest autologous material whenever a high-speed drill is being operated.

“We set out to be the standard in bone harvesting for multiple disciplines. We are moving quickly to accomplish this feat using our multi-patented technologies. Our universal device excels at high yield graft recovery designed to flow seamlessly in the OR setting for all staff that uses it,” Hensler said.

The HBP incorporates a clinically proven and patented two-step technique to harvest high speed drilled autologous material during bony decompressions, such as laminectomies, vertebral corpectomies, orthopedic and foot and ankle surgeries. This includes, but is not limited to; PLIF, TLIF, ACDF, PCF, vertebral partial/full corpectomies, scoliotic deformity, in-situ-fusions, orthopedic non-unions and foot and ankle surgeries. It is designed to be a high yield harvesting device with (2) 80 cc chambers. Disposable and easy to use, the HBP will be a valuable resource for surgeons within the CE observed countries, who desire to use the patients own autologous material for the fusion case.

The Hensler Bone Press is available through Hensler Surgical Technologies to hospitals, ambulatory care centers and stand-alone facilities across the global surgical health care market. It is a class IIa, disposable device manufactured in the USA.

For more information, visit



Submit a Comment

Your email address will not be published.